The basis for the post-parathyroidectomy increase in bone mass

Robert P. Heaney

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The bone remodeling transient is a self-limited change in measurable bone mass, detectable by dual-energy X-ray absorptiometry (DXA) or by calcium balance methods, which occurs whenever the skeleton undergoes a shift in bone remodeling activity from one steady state to another. Assessing the true effect on bone mass of therapy that alters remodeling requires both a period of observation long enough to characterize the new steady state and explicit provision for the transient. To help with such analysis, a multivariate computer model of the bone remodeling system has been developed and applied usefully to a variety of data sets describing the response to treatment. Because parathyroid hormone (PTH) is the principal determinant of the quantity of bone remodeling, it follows that efficacious treatment of hyperparathyroidism will produce a bone remodeling transient. Using published values for the level of bone remodeling activity in postmenopausal women with mild hyperparathyroidism, it can be calculated that successful treatment would produce an increase in measurable spine bone mineral density (BMD) of about 12% by 1 year after surgery. In more severe cases, with higher levels of remodeling, one-time BMD increases of more than 30% will occur. In general, it can be said that, in typical postmenopausal women, a doubling of remodeling rate in the hyperparathyroid state will, on successful treatment, produce a positive transient amounting to about 8% above the presurgery BMD level.

Original languageEnglish
JournalJournal of Bone and Mineral Research
Volume17
Issue numberSUPPL. 2
StatePublished - Nov 1 2002

Fingerprint

Parathyroidectomy
Bone Remodeling
Bone and Bones
Bone Density
Hyperparathyroidism
Therapeutics
Photon Absorptiometry
Parathyroid Hormone
Skeleton
Computer Simulation
Spine
Multivariate Analysis
Observation
Calcium

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

The basis for the post-parathyroidectomy increase in bone mass. / Heaney, Robert P.

In: Journal of Bone and Mineral Research, Vol. 17, No. SUPPL. 2, 01.11.2002.

Research output: Contribution to journalArticle

@article{c8d981890aad4364b8535075ae56cd3f,
title = "The basis for the post-parathyroidectomy increase in bone mass",
abstract = "The bone remodeling transient is a self-limited change in measurable bone mass, detectable by dual-energy X-ray absorptiometry (DXA) or by calcium balance methods, which occurs whenever the skeleton undergoes a shift in bone remodeling activity from one steady state to another. Assessing the true effect on bone mass of therapy that alters remodeling requires both a period of observation long enough to characterize the new steady state and explicit provision for the transient. To help with such analysis, a multivariate computer model of the bone remodeling system has been developed and applied usefully to a variety of data sets describing the response to treatment. Because parathyroid hormone (PTH) is the principal determinant of the quantity of bone remodeling, it follows that efficacious treatment of hyperparathyroidism will produce a bone remodeling transient. Using published values for the level of bone remodeling activity in postmenopausal women with mild hyperparathyroidism, it can be calculated that successful treatment would produce an increase in measurable spine bone mineral density (BMD) of about 12{\%} by 1 year after surgery. In more severe cases, with higher levels of remodeling, one-time BMD increases of more than 30{\%} will occur. In general, it can be said that, in typical postmenopausal women, a doubling of remodeling rate in the hyperparathyroid state will, on successful treatment, produce a positive transient amounting to about 8{\%} above the presurgery BMD level.",
author = "Heaney, {Robert P.}",
year = "2002",
month = "11",
day = "1",
language = "English",
volume = "17",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "SUPPL. 2",

}

TY - JOUR

T1 - The basis for the post-parathyroidectomy increase in bone mass

AU - Heaney, Robert P.

PY - 2002/11/1

Y1 - 2002/11/1

N2 - The bone remodeling transient is a self-limited change in measurable bone mass, detectable by dual-energy X-ray absorptiometry (DXA) or by calcium balance methods, which occurs whenever the skeleton undergoes a shift in bone remodeling activity from one steady state to another. Assessing the true effect on bone mass of therapy that alters remodeling requires both a period of observation long enough to characterize the new steady state and explicit provision for the transient. To help with such analysis, a multivariate computer model of the bone remodeling system has been developed and applied usefully to a variety of data sets describing the response to treatment. Because parathyroid hormone (PTH) is the principal determinant of the quantity of bone remodeling, it follows that efficacious treatment of hyperparathyroidism will produce a bone remodeling transient. Using published values for the level of bone remodeling activity in postmenopausal women with mild hyperparathyroidism, it can be calculated that successful treatment would produce an increase in measurable spine bone mineral density (BMD) of about 12% by 1 year after surgery. In more severe cases, with higher levels of remodeling, one-time BMD increases of more than 30% will occur. In general, it can be said that, in typical postmenopausal women, a doubling of remodeling rate in the hyperparathyroid state will, on successful treatment, produce a positive transient amounting to about 8% above the presurgery BMD level.

AB - The bone remodeling transient is a self-limited change in measurable bone mass, detectable by dual-energy X-ray absorptiometry (DXA) or by calcium balance methods, which occurs whenever the skeleton undergoes a shift in bone remodeling activity from one steady state to another. Assessing the true effect on bone mass of therapy that alters remodeling requires both a period of observation long enough to characterize the new steady state and explicit provision for the transient. To help with such analysis, a multivariate computer model of the bone remodeling system has been developed and applied usefully to a variety of data sets describing the response to treatment. Because parathyroid hormone (PTH) is the principal determinant of the quantity of bone remodeling, it follows that efficacious treatment of hyperparathyroidism will produce a bone remodeling transient. Using published values for the level of bone remodeling activity in postmenopausal women with mild hyperparathyroidism, it can be calculated that successful treatment would produce an increase in measurable spine bone mineral density (BMD) of about 12% by 1 year after surgery. In more severe cases, with higher levels of remodeling, one-time BMD increases of more than 30% will occur. In general, it can be said that, in typical postmenopausal women, a doubling of remodeling rate in the hyperparathyroid state will, on successful treatment, produce a positive transient amounting to about 8% above the presurgery BMD level.

UR - http://www.scopus.com/inward/record.url?scp=0036840408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036840408&partnerID=8YFLogxK

M3 - Article

VL - 17

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - SUPPL. 2

ER -